Project Grant CE153791

Award Date 9/30/24
Completion Date 9/30/27
Dollars Obligated $20M
Funding Federal Agency
Healthcare Systems Bureau
Federal Grant Program
93.493
Assistance Type
Project Grant
Place of Performance
Newark, DE, USA
Similar Awards
This $9,000,000 Project Grant award from the U.S. Department of Health and Human Services (HHS) under the Congressional Directives program (CFDA 93.493) will support the University of Mississippi's efforts to enhance their on-demand pharmaceutical manufacturing capabilities. The funding will enable the acquisition of state-of-the-art equipment to improve their capacity for dosage form characterization and point-of-care compounding. This investment will facilitate the university's research and...
This Project Grant award from the National Institute of Standards and Technology (NIST) under the Congressionally-Identified Projects program (CFDA 11.617) provides $7,250,000 to the University of Delaware to procure biopharmaceutical manufacturing equipment at the pilot/clinical scale. The equipment, including controlled rate freezers, bioreactors, filtration systems, and chromatography systems, will serve as a testbed for benchmarking current and future biopharmaceutical manufacturing...
The Department of Health and Human Services (HHS) awarded a $6,428,000 Project Grant under the Congressional Directives program (CFDA 93.493) to the Mount Desert Island Biological Laboratory (MDIBL) located in Bar Harbor, Maine. The purpose of this award is to expand MDIBL's capacity by creating a state-of-the-art research facility focused on developing novel models for drug discovery. This new facility will strengthen partnerships with pharmaceutical companies, foster greater collaborations...
This federal Project Grant award for $2,700,000.00, provided by the U.S. Department of Health and Human Services under the Congressional Directives program (CFDA 93.493), will fund the establishment of the inaugural D3B Center at the University of Mississippi. The center aims to become a world-renowned, self-sustaining hub for medical device innovation through translational research that links university researchers, industry partners, and students. The funding will provide additional working...
This $9,000,000 Project Grant award, funded by the U.S. Department of Health and Human Services under the Congressional Directives program (CFDA 93.493), will support the development of a Pharma Pilot Plant (PPP) facility at Kansas State University (K-State). The PPP will enable K-State researchers, corporate partners, and early-stage drug discovery companies to scale up the production of vaccines, therapeutics, and other biologic products from bench-scale to commercial-scale manufacturing. This...
The National Institute of Standards and Technology (NIST) has awarded a $2,475,000 Project Grant under the Congressionally-Identified Projects (CFDA 11.617) program to Delaware Innovation Space Inc. The purpose of this award is to acquire research-enabling laboratory equipment that will support rapid technology development and commercialization for startups in Delaware Innovation Space's incubator facility. The project will strengthen the incubator's 130,000 square foot wet laboratory by...
This two-year, $512,200 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) supports the development of a microbial "foundry" for distributed manufacturing of mRNA-containing biomaterials. Awarded on September 1, 2021 to Purdue University with a completion date of August 31, 2023, the grant will further the program's goals of advancing the biological sciences and strengthening the national scientific enterprise. Under this award, Purdue...
The National Science Foundation awarded a $365,567 Project Grant to the University of Delaware under the Biological Sciences federal grant program (CFDA 47.074). The funding will support the acquisition of a Sartorius Biolayer Interferometer Octet RH16 instrument for label-free detection of biomolecular interactions. The instrument will be used broadly in research and undergraduate training programs across multiple campuses, including the University of Delaware and surrounding Primarily...
The Department of Health and Human Services (HHS) awarded a $8,000,000 Project Grant under the Congressional Directives program (CFDA 93.493) to Cold Spring Harbor Laboratory (CSHL), a non-profit research and education institution in New York. The grant funds the construction and renovation of healthcare facilities, equipment purchases, and the delivery of specialized health and social services programs to address specific local and regional needs as directed by Congress. CSHL, which has...
This Cooperative Agreement award, valued at $415,769.00, was provided by the U.S. Army Research Development and Engineering Command (RDECOM) under the Basic Scientific Research program (CFDA 12.431). The award supports fundamental research by the University of Delaware to incorporate immune response into high-throughput bioprinted skin and lung models for the development of medical countermeasures. The research aims to expand scientific knowledge and understanding in areas critical to national...

This $20,000,000 Project Grant award from the U.S. Department of Health and Human Services (HHS) under the Congressional Directives program (CFDA 93.493) will support the continued design and construction of a Current Good Manufacturing Practices (CGMP) capable facility on the University of Delaware's Science, Technology, and Advanced Research (STAR) campus. The envisioned Securing American Biomanufacturing Research and Education (SABRE) Center will provide critical infrastructure to enable the development and manufacturing of cutting-edge biopharmaceuticals, such as gene therapies, monoclonal antibodies, and other related biopharmaceuticals. This award, with a performance period from September 30, 2024 to September 30, 2027, is part of a congressionally directed effort to bolster domestic biopharmaceutical manufacturing capabilities and innovation.

Generated 8/5/25, 5:22 AM